Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.9840
-0.0013 (-0.13%)
At close: Oct 7, 2026, 4:00 PM EDT
1.005
+0.021 (2.17%)
After-hours: Oct 7, 2026, 7:06 PM EDT

Allarity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
161753478
Market Cap Growth
-34.67%229.00%106.50%-40.12%-94.65%-
Enterprise Value
212-124373
Last Close Price
0.981.081.17330.66246787.068714405.71

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
45.3853.33----
PB Ratio
4.431.740.44-0.912.224.18
P/TBV Ratio
4.431.740.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
60.754.88----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
6.300.140.11-0.471.980.06
Net Debt / Equity Ratio
1.50-1.36-1.55-0.390.88-1.00
Net Debt / EBITDA Ratio
-0.491.061.04-0.06-0.100.71
Net Debt / FCF Ratio
-0.380.901.03-0.08-0.101.27
Asset Turnover
0.010.02----
Quick Ratio
0.641.862.010.080.261.03
Current Ratio
1.112.132.060.140.441.03
Return on Equity (ROE)
-157.09%-103.80%-541.17%--155.34%-123.30%
Return on Assets (ROA)
-25.31%-38.52%-63.52%-81.08%-32.90%-39.98%
Return on Capital Employed (ROCE)
-305.30%-128.30%-148.50%743.10%-508.50%-91.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-78.78%-65.81%-472.60%-473.76%-382.75%-33.98%
FCF Yield
-88.03%-86.89%-340.25%-507.36%-401.27%-18.98%
Buyback Yield / Dilution
-92.11%-794.77%----
SEC Filings: 10-K · 10-Q